Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Peter pomaga mami. [undo]
  • Πανοραμική ακτινογραφία. [undo]
  • Quantification of bacterial load: Serial dilutions [undo]
  • Description of cells 3 [undo]
  • [undo]
  • Opțiunea 1: Pentru siguranța noastră și a colegilor noștri în timpul și după practica de laborator [undo]
  • Examination [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway